SSSatish Kumar Sadasivan

Satish Kumar Sadasivan

*This is an algorithmically generated author record based on publicly available information.

Satish Kumar Sadasivan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fast food diet with CCl4 micro-dose induced hepatic-fibrosis –a novel animal model

    by Tarak K Chheda, Pratibha Shivakumar, Satish Kumar Sadasivan, Harish Chanderasekharan, Yogananda Moolemath, Anup M Oommen, Jagannath R Madanahalli, Venkataranganna V Marikunte

    Non-alcoholic fatty liver disease (NAFLD) is defined as a spectrum of conditions ranging from hepatocellular steatosis to steatohepatitis and fibrosis, progressing to cirrhosis, which occur in the absence of excessive alcohol use. Several animal models capture aspects of NAFLD but are limited either in their representation of the disease stages or use for development of therapeutics due to the extended periods of time required to develop full histological features.


  • Open Access

    Modulation of de novo purine biosynthesis leads to activation of AMPK and results in improved glucose handling and insulin sensitivity

    by Satish Kumar Sadasivan, Balamuralikrishna Vasamsetti, Jaideep Singh, Nethra Siddaraju, Khaiser Mehdi Khan, Anup Mammen Oommen, Madanalli R Jagannath, Raghavendra Pralhada Rao

    Background: AMP activated protein kinase (AMPK) regulates key metabolic reactions and plays a major role in glucose homeostasis. Activating the AMPK is considered as one of the potential therapeutic strategies in treating type-2 diabetes. However, targeting AMPK by small molecule mediated approach can be challenging owing to diverse isoforms of the enzyme and their varied combination in different tissues. In the current study we employ a novel strategy of achieving AMPK activation through increasing the levels of cellular AMP (an allosteric activator of AMPK) levels by activating the enzyme involved in AMP biosynthesis namely Adenylosuccinate lyase (ADSL). Methods: Rat primary hepatocytes were cultured under metabolic overload conditions (500 μM palmitate) to induce insulin resistance. ADSL was overexpressed in these hepatocytes and its effect on hepatic glucose output, and triglyceride accumulation was checked. In addition to this, ADSL was overexpressed in high fat diet induced obese mice by hydrodynamic tail vein injection and its effect on fasting glucose, glucose tolerance and pyruvate tolerance were checked. Results: Rat primary hepatocytes when cultured under metabolic overload conditions developed insulin resistance as measured in terms of failure of insulin to suppress the glucose output. Overexpressing the ADSL in these hepatocytes resulted in increased AMPK phosporylation and improved the insulin sensitivity and also resulted in reduced triglyceride accumulation and inflammatory cytokine levels. In addition to this, when ADSL was overexpressed in high fat diet induced obese mice, it resulted in reduced the fasting hyperglycemia (20% reduction), and increased glucose and pyruvate tolerance. Conclusions: This study indicates that activating ADSL can be a potential mechanism to achieve the activation of AMPK in the cells. This leads to a novel idea of exploring the purine nucleotide metabolic pathway as a promising therapeutic target for diabetes and metabolic syndrome.


  • Exogenous administration of spermine improves glucose utilization and decreases bodyweight in mice

    by Satish Kumar Sadasivan, Balamuralikrishna Vasamsetti, Jaideep Singh, Venkataranganna V. Marikunte, Anup Mammen Oommen, M.R. Jagannath, Raghavendra Pralhada Rao